New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Trial ID or NCT#
NCT0662038
Status
NOT RECRUITING
Purpose
This is an open-label, multi-center, extension study for patients with IPF who complete a qualifying InterMune clinical trial of pirfenidone. The purpose of this study is to obtain additional safety data for pirfenidone 2403 mg/day in patients with IPF who complete a qualifying InterMune clinical trial of pirfenidone.
Investigator(s)
Contact us to find out if this trial is right for you.
CONTACT
Susan Jacobs
(650) 725-8083
View on ClinicalTrials.gov